We added the following clinical trials to Metastatic Trial Search for October 2026. To see all clinical trials, please visit Metastatic Trial Search.
ER/PR Positive Trials
- TheraBionic P1 Device for Women with Advanced Hormone Receptor Positive (ER+ and/or PR+), HER2 Negative (HER2-) Breast Cancer
- Targeted Therapy (Inavolisib) plus Ribociclib (Kisqali®) and Fulvestrant (Faslodex®) for HR Positive, HER2 Negative Advanced Breast Cancer Without a PIK3CA Mutation
HER2 Positive Trials
- RO7771950 or Tucatinib, with Trastuzumab and Capecitabine, for HER2 Positive Metastatic Breast Cancer, with or without Brain Metastases
- Asciminib and Trastuzumab for Women with Metastatic HER2 Positive (HER2+) Breast Cancer with Brain Metastases
Triple Negative Trials
- ARV-6723 with or without Immunotherapy (Pembrolizumab) for Advanced or Metastatic Triple Negative (ER-, PR-, HER2-) Breast Cancer
- N17350 for Advanced Triple Negative (ER-, PR-, HER2-) Breast Cancer
Other Trials
- Stereotactic Radiosurgery (SRS) Before Surgery for Breast Cancer That Has Spread to the Brain (Brain Metastases)
- Romosozumab for Women with Hormone Receptor Positive (ER+ and/or PR+) Metastatic Breast Cancer That Has Spread to the Bones with Osteoporosis
Non- Treatment Trials
- Spinal Fluid (CSF) Collection Study for Women with Metastatic Triple Negative or HER2 Positive Breast Cancer
- A Virtual Group Lifestyle Program for Women with Metastatic (Stage IV) Hormone Receptor Positive, HER2 Negative Breast Cancer
- Talk Therapy to Improve Cancer Distress in People with Metastatic Breast Cancer
- Preventing Rash and Diarrhea From Capivasertib for Advanced Hormone Receptor Positive, HER2 Negative Breast Cancer With a PIK3CA, AKT1, or PTEN Mutation
- Symptom Management and Coaching for People with Metastatic Breast Cancer and Their Caregivers
- MRI to Help Detect Breast Cancer That Has Spread to the Lining of the Brain and Spinal Cord (Leptomeningeal Disease)
- Home Based Exercise Program to Preserve Strength and Prevent Disability During Chemotherapy for People With Breast Cancer
- A Counseling Study (Meaning Centered Psychotherapy) for Latinos with Advanced Breast Cancer
- Prolonged Fasting With Capivasertib (Truqap®) for Metastatic Breast Cancer
- A Decision Support Tool (COAST) for People With Metastatic Breast CancerA Decision Support Tool (COAST) for People With Metastatic Breast Cancer
- Side Effects and Resource Navigation Program for People With Breast Cancer Receiving Immunotherapy
- Patient Navigation Program for Women With HER2 Positive (HER2+) Metastatic (Stage IV) Breast Cancer
Last Modified on October 2, 2026